This might explain the altered ratios of bioactive to immunoreactive LH or hCG that are frequently described in patients with hypogonadism [40], poor fertility [41-43], ovarian dysfunction [42,43], miscarriage [44-46] and other early pregnancy complications [47]. This evidence concerns the gene PLOD1 and ovarian dysfunction.